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INTRODUCTION
Transcription factors are central to achieving specificity of the
cellular responses to extracellular signals. Jun proteins are
major components of the AP-1 transcription factor and show
tissue-specific and differential expression during embryonic
development (Wilkinson et al., 1989; Angel and Karin, 1991).
c-Jun, JunB and JunD differ in their DNA-binding properties,
displaying distinct and sometimes opposite roles (Ryseck and
Bravo, 1991; Castellazzi et al., 1991). c-jun knock out mice die
in utero and cells lacking c-jun show retarded growth in
culture, suggesting that c-jun is critical for the control of cell
proliferation (Johnson et al., 1993). On the other hand, Jun
signalling has been implicated in the regulation of cell
differentiation (Treier et al., 1995) and apoptosis (Marti et al.,
1994; Eilers et al., 1998). Jun proteins are activated by
phosphorylation through two distinct pathways: first, survival
factors induce the activation of certain mitogen-activated
kinases (MAPKs) which induce c-jun expression and
stimulation of cell proliferation. Secondly, the activation of
another set of MAPKs, the Jun amino-terminal-kinases
(JNKs), leads to apoptosis (Karin et al., 1997). JunD is
phosphorylated less efficiently than c-Jun while JunB is not
phosphorylated by JNKs. This indicates that not only the
expression but also the specific phosphorylation of Jun may
determine the functions played by the different Jun proteins. 
The precise role of Jun in the regulation of cell death,
survival and differentiation during embryonic development is
still poorly understood. The molecular correlates of early
developmental decisions in ear ontogenesis are beginning to be
identified, providing an attractive model system to study the
specificity of AP-1 signalling. Insulin-like growth factor-I
(IGF-I) and nerve growth factor (NGF) regulate cell number
and cell differentiation in the developing inner ear (Torres and
Giráldez, 1998; Frago et al., 1998). IGF-I activates the
Raf/MAPKs pathway, and increases Fos and Jun levels (Sanz
et al., 1999). Antisense c-fos and c-jun oligonucleotides
partially block the proliferative effect of IGF-I (León et al.,
1995a, 1998). These results indicate that Fos/Jun heterodimers
govern proliferative growth of the otic vesicle. However, in
cultured otic vesicles the expression of c-jun transcripts
coincides with areas of NGF-induced cell death (Frago et al.,
1998), suggesting that Jun proteins may play a dual role during
early inner ear development. 
Here we show the presence of c-jun and junD transcripts in
the otic pit, otic vesicle and cochleo-vestibular ganglion
(CVG), along with the phosphorylation of c-Jun at serine-63
residue within the same areas during the early stages of inner
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Jun transcription factors have been implicated in the
regulation of cell proliferation, differentiation and
apoptosis. We have investigated the relationship between
Jun expression and cell death in the developing chicken
inner ear. c-jun and junD transcripts were expressed in the
epithelium of the otic placode and otic vesicle. c-jun
expression was restricted to the dorsal area of the otic pit
(stages 14-17), dorsal otic vesicle and cochleo-vestibular
ganglion (stages 18-20). junD expression was transient and
occurred in the dorsal and upper medial aspects of the otic
pit and otic cup, but it was down-regulated in the otic
vesicle. A parallel TUNEL analysis revealed that expression
of c-jun co-located within areas of intense apoptosis.
Furthermore, phosphorylation of c-Jun at serine-63 by Jun
amino-terminal-kinases was detected in the dorsal otic pit,
otic vesicle and cochleo-vestibular ganglion. c-Jun protein
exhibited DNA binding activity, as assessed by gel mobility
shift assays. The association between c-Jun and apoptosis
was further demonstrated by studying nerve growth factor-
induced apoptosis in cultured otic vesicles. Nerve growth
factor-induced cell death and c-Jun phosphorylation that
were suppressed by insulin-like growth factor-I and by
viral-mediated overexpression of Raf, which had survival
effects. In conclusion, the precise regulation of the
expression and activity of Jun proteins in the otic
primordium suggests that it may operate as a fundamental
mechanism during organogenesis. 
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ear development. The functionality of c-Jun protein was
established by determining its ability to interact with an
specific AP-1 recognition site. Mapping of apoptotic regions
revealed that c-Jun expression and phosphorylation domains
overlapped with areas of high apoptotic activity. Furthermore,
NGF increases c-Jun phosphorylation in parallel with the
induction of apoptosis in cultures of explanted otic vesicles,
and this increase is inhibited by IGF-I or viral-mediated
overexpression of Raf. These results suggest that Jun
transcription factors may specify proliferative and apoptotic
areas within the otic vesicle and link extracellular signals to
long-term cellular responses during organogenesis. 
MATERIALS AND METHODS
Materials
Recombinant NGF was from UBI (Lake Placid, NY). Human IGF-I
was purchased from Boehringer Mannheim (Mannheim, Germany).
Anti-phosphorylated-c-Jun (KM-1) is a mouse monoclonal IgG1
antibody raised against a peptide corresponding to amino acids 56-69
of human c-Jun, it reacts with c-Jun p39 phosphorylated at serine-63
of different species. It shows no cross-reactivity with JunB or JunD
phosphorylated on the analogous serine residues or with c-Jun non-
phosphorylated at serine-63 (Santa Cruz Biotechnology Inc., Santa
Cruz, CA). Anti-c-Jun (sc-45X) used for gel supershift assays was
from Santa Cruz. The Cell Death Detection and In situ Cell Death
Detection-POD kits were from Boehringer Mannheim.
Chicken embryos were obtained from fertilised eggs (Granja
Rodríguez Serrano, Salamanca, Spain) that were incubated at 38°C in
a humidified atmosphere. The embryos were staged according to
Hamburger and Hamilton criteria (1951). Animal care and handling
complied with the guidelines of the European Community directive
(86/69/CEE) and the Spanish legislation (R.D. 223/1988) and was
approved by the Committe of Biosafety and Animal Care of the IIB.
Otic vesicle isolation, cell culture and production of viral
stocks
Otic vesicles were dissected from embryos corresponding to stage 18
using a dissection stereomicroscope (Nikon SMZ-2T), transferred
into four-well culture plates (NUNC Roskilde, Denmark) and
incubated at 37°C in a water-saturated atmosphere containing 5% CO2
as described (Miner et al., 1988; León et al., 1995b, 1998). The
standard culture medium consisted of serum-free M199 medium with
Earle’s salts (Biowhittaker, Walkersville, MD) supplemented with
2 mM glutamine (Biowhittaker), and antibiotics (penicillin, 50 i.u./ml
and streptomycin, 50 mg/ml) (Biochrom, Berlin, Germany). FBS was
purchased from Biowhittaker.
Line 0 CEF were prepared as described by Hunter (1979) from
embryonic day 10 chicken and cultured in growth medium (DMEM,
10% FBS, 2% chicken serum, penicillin/streptomycin and glutamine
as above).
RCAS is a replication-competent retroviral vector derived of Rous
sarcoma virus (Hughes et al., 1987). It contains a ClaI site for cloning
of exogenous genes. RCAS envelope subgroup A vector was the
generous gift of Dr S. Hughes (National Cancer Institute-Frederick,
MD). c-raf cDNA (gift from Dr U. Rapp, University of Würzburg,
Germany) (Heidecker et al., 1990) was inserted into RCAS at the ClaI
site as described by Sanz et al. (1999) and RCAS clones containing
the c-raf inserts in the sense orientation (RCAS/RAF) were identified
and isolated. CEF were transfected with 10 mg of the plasmid
containing the provirus by calcium phosphate co-precipitation
(Petropoulos and Hughes, 1991). Transfected cells were then
passaged and expanded for 10 days in CEF culture medium; at
the end of that period all cells were infected, as estimated by
immunohistochemistry with anti-p27 antibody that was a generous
gift of Dr Volker M. Vogt (Cornell University, NY). Viral supernatants
were collected in culture medium on the following two days and
concentrated 100-fold by centrifugation (3 hours, 28,000 rpm). Then,
the titer of the viral stock was determined as described by Fekete and
Cepko (1993). Positive colonies were identified and counted to obtain
the titer that is defined as colony-forming units per ml (cfu/ml). Titers
were typically in the range 2-3 · 108 cfu/ml. Two viral preparations
were used for these studies with similar results.
Infected-CEF cells were plated in cell culture inserts to a density
of 8 · 104 cells/insert and co-cultured with otic vesicle explants at 37°C
and 5% CO2 for 24 hours as described by Sanz et al. (1999). The
degree of infection was estimated by western blotting or
immunohystochemistry with anti-p27 antibody. When indicated,
explants were cultured for a further period of 16 hours in the presence
or absence of 1 nM IGF-I or 4 nM (100 ng/ml) NGF. Otic vesicles
were homogenised individually and the cell extracts subjected to
enzyme-linked immuno-assay (ELISA) determination (Frago et al.,
1998). In parallel, five explants per condition were fixed in 4% (w/v)
paraformaldehyde and the levels of jun phosphorylation determined
by immunohistochemistry.
Whole mount in situ hybridisation
In situ hybridisation was performed as described by Goulding et al.
(1994) with the modifications reported by León et al. (1998) using
digoxigenin-labelled RNA chicken probes for c-jun (Bos et al.,
1990) and junD (Hartl et al., 1991) kindly provided by Drs M. Zenke
(Max Delbrück Center, Berlin, Germany) and M. Hartl (University
of Innsbruck, Austria), respectively. A single-stranded c-jun RNA
antisense probe was prepared by the transcription of the linearised
plasmid pGEM7Z-CJ-3 with EcoRI using SP6 RNA polymerase
(Promega, Southampton, UK). Control sense probe was prepared by
linearising the plasmid with BamHI and using T7 RNA polymerase
(Promega). An EcoRI fragment of JunD was extracted from the
plasmid JunD-bluescript and inserted in PAJ10 bluescript. The sense
and antisense riboprobes were prepared by transcription of the
linearised plasmid with BamHI and HindIII and using T7 and T3
RNA polymerases, respectively. For hystological examination, after
in situ hybridisation the embryos were post-fixed in 4%
paraformaldehyde, embedded in gelatine-albumin and sectioned
with a vibratome (Leica VT 1000 M, Heidelberg, Germany) at a
thickness of 60 m m. 
Immunohistochemistry
This procedure was performed on frozen sections obtained from at
least ten embryos (stage 14 to 19). Whole embryos were fixed in 4%
(w/v) paraformaldehyde and cryoprotected in sucrose. Embryos were
coated with Tissue Tek (Sakura Finetek, Torrance, CA) and sectioned
(20 m m, Leitz cryostat, Jena, Germany). Sections were placed on poly-
L-lysine-coated slides and stored at - 20°C until use. Sections were
washed with 0.1 M PBS, pH 7.4, for 1 hour, treated for 30 minutes
with 0.3% Triton X-100 in PBS and for a further period of 30 minutes
with PBS, pH 7.4, solution containing 2% bovine serum albumin and
5% goat serum. Afterwards, sections were incubated overnight with
an anti-phospho-c-Jun mouse monoclonal antibody (KM-1) (Santa
Cruz Biotechnology) diluted 1:200 in PBS containing 2% bovine
serum albumin and 5% goat serum. Sections were then processed with
an anti-mouse antibody (EnVision, DAKO, Carpinteria, CA) and
developed with the peroxidase reaction. Control sections were
incubated with preimmune serum instead of the primary antibody and
then processed as described above. Sections were dehydrated and
mounted in the mounting medium Entellan (Merck, Darmstadt,
Germany). Microphotographs were taken in a Zeiss microscope
Axiophot. Computer-generated photomicrographs were produced by
scanning the obtained slides with a Nikon CoolscanII using the
programs Adobe Photoshop LE 2.5 and MacDraw Pro on Macintosh
computers.
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Cell death determination by TUNEL staining and
immunoassay
Distribution of apoptotic cells in the otic vesicle was determined by
TUNEL staining as described by Sgonc et al. (1994). This procedure
allows the detection of individual apoptotic cells in frozen tissue
sections. Fragmented DNA was labelled by the terminal
deoxynucleotidyl transferase-mediated fluorescein-dUTP nick end
labelling reaction according to the manufacturer’s instructions
(Boehringer Mannheim). Slides were then rinsed 3 times with PBS
and incubated with the Converter-horseradish peroxidase (POD)
solution (anti-fluorescein antibody conjugated with POD,
Boehringer Mannheim). Apoptotic nuclei were visualised with DAB
and analysed by light microscope with a Zeiss Axiophot
Microscope. 
Quantification of cell death was performed by using the Cell Death
Detection ELISA from Boehringer Mannheim, basically as indicated
by the manufacturer and described by Frago et al. (1998).
Preparation of nuclear extracts and electrophoretic
mobility shift assay
Nuclear extracts were prepared from otic vesicles isolated from 100
embryos (stage 20). At this stage the CVG is attached to the otic
vesicle, both structures were isolated and analysed together. The
procedure followed was essentially as described elsewhere (Andrews
and Faller, 1991), but 0.2% Triton X-100 was included in the
hypotonic lysis buffer. Nuclear proteins were extracted with high salt
buffer containing 20 mM Hepes, pH 7.9, 0.4 M KCl, 0.2 mM EDTA,
1.5 mM MgCl2, 1 mM dithiotreitol, 0.2 mM phenylmethylsulphonyl
fluoride, 0.5 mg/ml leupeptin, 10 mg/ml soybean trypsin inhibitor, and
25% glycerol. Nuclear extracts were aliquoted and stored at - 70°C
until used. Protein concentration was determined with the Bradford
protein assay kit (Bio-Rad).
The double-stranded oligonucleotide probes used in the
electrophoretic mobility shift assay were jun1TRE (upper strand, 5 ¢ -
AGCTGGGGTGACATCATGGG-3¢ ) and jun2TRE (upper strand, 5 ¢ -
AGCTAGCATTACCTCATCCC-3¢ ) that are derived from the
proximal and distal AP-1 binding sites of the human c-jun promoter,
respectively (Angel et al., 1988; van Dam et al., 1993). The
oligonucleotide 5¢ -GCTTTGGCATGCTGCCAATATG-3¢ , containing
a consensus NF-1 binding site (Jones et al., 1987), was used as non-
specific competitor. DNA binding assay was carried out in a 20-ml
reaction containing 10 mg of otic vesicle nuclear proteins, 40 mM
Hepes, pH 7.5, 80 mM KCl, 0.2 mM EDTA, 5 mM MgCl2, 1.25%
Ficoll, 1 mg poly(dI-dC).poly(dI-dC), 1 mg of sonicated herring
sperm DNA, and, when indicated, a 50-fold molar excess of
competitor oligonucleotide. The reaction mixtures were incubated on
ice for 15 minutes, then 8· 104 cpm of annealed oligonucleotides were
Fig. 1. Expression of c-jun during the early development of the inner
ear. Microphotographs from vibratome sections obtained after whole
mount “in situ” hybridisation. Chicken embryos between stages 14 to
20 were dissected and in situ hybridisation performed as described in
Materials and Methods, using digoxigenin-labelled RNA chicken
probes for c-jun. After hybridisation the embryos were post-fixed in
4% paraformaldehyde, embedded in gelatine-albumin and sectioned
at 60 m m with a vibratome. Arrowheads point to the c-jun transcript
expression. The pattern of c-jun expression shown is representative
of 4 different experiments, with at least 5 embryos per stage. Bar,
150 m m. A, anterior; D, dorsal; op, otic pit; CVG, cochleovestibular
ganglion; ed, endolymphatic duct.
Fig. 2. Expression of junD in the otic placode and the otic cup.
Chicken embryos were dissected at stages 14 to 19 and in situ
hybridisation was performed as described, with a chicken junD
probe. Photographs from 60 m m vibratome sections. Arrowheads
point to the junD transcript expression. The experiment shown is
representative of 3 performed with at least 5 embryos per stage. Bar,
100 m m. A, anterior; D, dorsal; op, otic pit; CVG, cochleovestibular
ganglion.
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added and incubation continued for an additional period of 15
minutes. For gel supershift assays, nuclear proteins were incubated
with either 0.5 mg or 2 mg of anti-c-Jun antibody for 30 minutes prior
to the addition of the labelled probe. The DNA-protein complexes
were resolved in a 5% polyacrylamide gel in 0.5· TBE (1 · TBE: 89
mM Tris, pH 8.0, 89 mM boric acid, 2 mM EDTA).
RESULTS
Expression of Jun transcription factors
In stage 14, c-jun transcripts were expressed at the dorsal ridge
delimiting the otic pit from the surrounding ectoderm (Fig. 1).
In stages 14 to 17, as the otic pit invaginated, c-jun expression
was maintained in the otic pore, with an intense dorsal and
caudal expression domain. In stages 18, 19 and 20 (Fig. 1), c-
jun expression was restricted to the dorsal epithelium, and it
was also expressed in the CVG. Dorsal expression of c-jun
seemed to extend through a narrow belt at the basis of the
endolymphatic duct. Northern blot analysis performed on poly-
A mRNA preparations of stage 20 otic vesicles revealed also
a 2.7 kb transcript that was identified with a chicken c-jun
probe (León et al., 1998). However, comparison of c-jun
expression pattern with previously reported Jun induction and
Jun immunoreactivity (see Discussion) suggested that, most
probably, c-jun was not the singular member of the Jun family
of factors expressed in the otic vesicle. Since junB has not been
cloned from avian cells, the next step was to study the pattern
of expression of junD.
junD was expressed in the otic placode and the otic cup.
junD transcripts were present in the upper medial epithelium
of the otic vesicle and in the CVG (Fig. 2). junD expression
was transient and it was not detected from stage 18 onwards in
the epithelium of the otic vesicle (Fig. 2, stage 18 and stage
19). Patches of junD expression associated with neural crest
cell migration were also apparent. JunD expression still did not
account for Jun immunoreactivity associated with the ventral
and medial cell proliferation activity of the otic vesicle,
suggesting the existence of other avian Jun family members
which have not been cloned yet. However, both c-jun and junD
expression seemed to be associated with areas which have been
traditionally described of intense cell death (Alvarez and
Navascues, 1990). 
It has been widely documented that Jun proteins mediate
transcriptional stimulation through its interaction with specific
DNA sequences (Karin et al., 1997). To assess the functionality
of c-jun expression in the inner ear, we explored the DNA
binding activity of the c-Jun protein by gel mobility shift
assay. For this purpose, a double-stranded oligonucleotide
(jun2TRE), which specifically recognises c-Jun-c-Jun
homodimers or c-Jun-ATF-2 heterodimers (van Dam et al.,
1993), was used as a probe. As shown in Fig. 3, distinct DNA-
protein complexes were detected when the radiolabelled probe
was incubated with nuclear extracts prepared from otic vesicles
(stage 20). The two complexes of slower mobility were
completely abolished by the addition of excess unlabelled
probe, but not by a 50-fold molar excess of an unrelated
oligonucleotide containing a binding site for NF-1. Presence
of c-Jun in both complexes was confirmed by supershifting
with an antibody to c-Jun. Addition of antibody to the binding
reaction resulted in a reduction in the intensity of the retarded
bands and the appearance of a weak supershifted band (Fig. 3,
closed and open arrowheads, respectively). The intensity of
other bands was not affected by the addition of anti-c-Jun
antibody. Similar results were obtained when jun1TRE
oligonucleotide was used as a probe (data not shown),
jun1TRE recognises different AP-1 factors including c-Jun
dimers (Ryseck and Bravo, 1991).
Phosphorylation of c-Jun at serine-63 in the
developing inner ear
JNKs are members of the MAPKs family whose activation is
elicited during apoptosis induced by factors deprivation
(Kaplan and Miller, 1997; Leppä et al., 1998) or by NGF (Yoon
et al., 1998). JNKs phosphorylate c-Jun at serines 63 and 73
(Karin et al., 1997). This phosphorylation step activates c-Jun
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Fig. 3. Gel mobility shift assay of otic vesicle nuclear proteins
interacting with an AP-1 site. Labelled double-stranded
oligonucleotide jun2TRE was incubated with 10 mg of nuclear
extracts prepared from stage 20 otic vesicles. For competition, 50-
fold molar excess of unlabelled probe or of unlabelled
oligonucleotide containing a consensus NF-1 binding site were used.
Prior to the addition of the probe some of the mixtures were
incubated for 30 minutes on ice with either 0.5 mg or 2 mg of anti-c-
Jun-antibody. The position of the specific protein-DNA complexes
are indicated with closed arrowheads. The open arrowhead indicates
the supershifted complex. Binding reactions were separated by
electrophoresis in a native 5% polyacrylamide gel. DNA-protein
complexes are indicated by arrowheads. The experiment shown is
representative of at least three independent ones.
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distinctly and leads to an increase in apoptosis. To study the
role of c-Jun activation in natural cell death during inner ear
development we studied whether c-Jun was phosphorylated
by JNKs at the serine-63 residue. The pattern of c-Jun
phosphorylation was analysed from stage 14 to 20 by
immunohistochemistry with a monoclonal antibody raised
against the phosphorylated-c-Jun protein. Fig. 4 shows
phospho-c-Jun expression during stages 14 and 19. c-Jun
phosphorylation was high at the upper dorsal-caudal edge of
the otic pit. In stage 19-20 spots of stained cells were present
in the dorsal aspect of the otic vesicle and in the CVG. 
Programmed cell death during early otic
development
Cells undergoing apoptosis have several morphological
characteristics that include membrane blebbing, chromatin
condensation, DNA fragmentation and formation of apoptotic
bodies that are finally phagocytosed by the surrounding cells.
The TUNEL technique takes advantage of DNA fragmentation
occurring during apoptosis allowing DNA to be labelled in situ
by the terminal deoxynucleotidyl transferase. We used this
technique to carefully map cell death areas during the
formation of the otic vesicle (Fig. 5). In stage 14, the edges of
the otic cup presented a high number of labelled cells.
Labelling remained intense in this area until the formation of
the otic pore, at the closure of the otic cup to form the otic
vesicle (Fig. 5, stages 14 to 18). Latter in development, cell
death was detected as scattered cells concentrated in the dorsal-
caudal aspect of the otic vesicle around the formation of the
endolymphatic duct (Fig. 5, stages 19 and 20). Apoptotic cells
were also observed in the ventromedial aspect of otic
epithelium, a region from which cells migrate to form the
CVG, and also within the CVG (Fig. 5, stage 19 and stage 20).
The above description based on the TUNEL technique is in
agreement with previous reports using morphological criteria
(Alvarez and Navascues, 1990) and complete the description
reported by Fekete et al. (1997). 
NGF-induction of cell death is associated with c-Jun
serine-63-phosphorylation in the otic vesicle
To further study the relationship between c-jun and
programmed cell death in the inner ear, we used organotypic
cultures of explanted otic vesicles to test the effect of apoptotic
and survival factors on c-Jun phosphorylation. NGF induces
apoptotic cell death in the dorsal and ventromedial epithelium
of the otocyst, and in the CVG (Frago et al., 1998). On the
other hand, overexpression of Raf by means of retroviral RCAS
vectors suppresses NGF induction of apoptosis and potentiates
IGF-I actions as survival factor (Sanz et al., 1999). Otic
vesicles were explanted and co-cultured with either CEF or
CEF overexpressing Raf for 24 hours, the explants were then
cultured for a further period of 16 hours in the absence of
serum or presence of factors. Otic vesicles cultured under these
conditions exhibited increased apoptosis with respect to otic
vesicles cultured in the presence of FBS (Fig. 6A). As shown
in Fig. 6, NGF increased phospho-c-Jun staining as evidenced
by immunohistochemistry with an antibody specific for
phospho-c-Jun C). Both IGF-I (B) and the infection with
RCAS/RAF vectors (D) prevented NGF effects on c-Jun
phosphorylation. To quantify the effects in cell death resulting
from the addition of NGF and NGF plus IGF-I or Raf
overexpression, soluble nucleosomes were measured in otic
vesicle extracts by using a Cell Death Detection ELISA kit.
NGF was a potent inductor of apoptosis and IGF-I was able to
suppress NGF-induced apoptosis in otic vesicle organotypic
cultures (Table 1). Overexpression of Raf also blocked the
response to NGF. Therefore, NGF treatment increased the
phosphorylation of c-Jun at serine 63 and cell death, and this
effect was prevented by survival factors, in parallel with their
ability to suppress cell death.
DISCUSSION
A strict balance between cell proliferation and programmed
cell death enables the developing organism to control cell
number and form. The molecular mechanisms underlying these
biological processes are beginning to be understood. A
classical route to induce cell proliferation starts after growth
factor binding to tyrosine kinase receptors. This is followed by
the activation of a cytoplasmic kinase cascade which, in turn,
acts on a panel of nuclear targets that results in changes in gene
expression. c-fos and c-jun were soon identified as early genes
induced by mitogens, and components of the transcription
factor AP-1 (Karin et al., 1997). However, more recently it has
been described an alternative route that signals apoptosis that
involves c-Jun phosphorylation by JNKs (Karin et al., 1997).
These findings rise the question of how a cell in a developing
organ will take the decision to die or else to survive, on the
basis of a given pool of genes encoding proteins that can play
opposite roles.
In the present work, we have approached this question by
comparing the expression of the avian Jun family members
with the pattern of cell death and cell proliferation, during the
early development of the inner ear. c-jun and junD are
expressed in the dorsal edge of the otic cup (stages 14-17).
Expression of both c-jun and junD is very high in the otic pore,
but while c-jun expression is restricted to a dorsal narrow band,
junD expands to the ventromedial aspects of the otic cup.
Thereafter, the temporal pattern of expression of c-jun and
junD are also different. In the early otic vesicle (stage 18), the
expression of c-jun is maintained while junD is not.
Concomitantly, the otic vesicle enters a period of high cell
Table 1. Blockage of NGF-induced cell death
- RCAS/RAF
Control 100 100
IGF-I 75±5 (9)* 52±4 (15)*
NGF 159±13 (10)*,‡ 87±3 (14)§
NGF + IGF-I 78±5 (12)*,¶ 60±5 (4)¶
Otic vesicles were dissected from embryos corresponding to stage 18.
Control CEF ( - ) or infected-CEF (RCAS/RAF) cells were plated in cell
culture inserts to a density of 8· 104 cells/insert and co-cultured with otic
vesicle explants in 2% FBS for 24 hours. Explants were cultured for a further
period of 16 hours in the absence of FBS (control) or in the presence of 1 nM
IGF-I, 4 nM (100 ng/ml) NGF or NGF plus IGF-I. Otic vesicles were
homogenised individually and the cell extracts subjected to ELISA
determination. NGF and IGF-I data have been previously reported by Sanz et
al. (1999). For each experimental condition the absorbance obtained with otic
vesicles cultured in the absence of additives was given a value of 100. Results
are mean ± s.e.m. of the number of explants tested in at least 3 different
experiments. Statistical significance is as follows: *P<0.001 and §P<0.01 vs
control, ¶P<0.001 vs NGF, and ‡P<0.001 vs RCAS/RAF plus NGF.
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proliferation that is mainly supported by the cells located at its
medioventral aspect (De la Pompa, 1995). junD has been
associated with inhibition of cell growth (Pfarr et al., 1994).
Therefore, the observed down-regulation of junD from
potential proliferative areas could be required to allow the burst
of cell proliferation in the otic vesicle. Jun proteins form either
homodimers or heterodimers with different proteins
that include the Fos-related proteins, ATF-2 and
CREB. Dimerization takes place through leucine
zipper domains and allows binding to DNA
sequences, that are present in the target genes (Karin
et al., 1997). There are a large number of different
combinations of dimers that allow specific
transcriptional responses. Fos is homogeneously
expressed in the otic vesicle, although with intense
levels in the ventral and medial aspects (León et al.,
1995b, 1998). Under the assumption that Fos requires
of a Jun counterpart to induce cell proliferation, it can
be speculated that Fos requires of a yet unknown Jun
protein for the induction of AP-1. The central
argument rests on the observation that the ventral
expression of Fos, where most proliferating activity
occurs, is no accompanied by any known Jun member,
but it is associated with the detection of Jun protein
by means of a highly conserved antibody.
As mentioned above, c-jun expression is high in the
dorsal aspect of the otic vesicle and in the CVG from
stages 14 to 20, the latest stage studied. Up to stage
17, c-jun expression intersects with that of junD, but
then, there is no other Jun counterpart yet described.
Therefore, either c-Jun or JunD homodimers or c-Jun/JunD
heterodimers are probably the majority forms of AP-1 in the
dorsal otic primordium. This is precisely the region where
apoptosis occurs most intensely (see below).
Our gel retardation experiments provide the evidence that c-
Jun protein in the otic vesicle is effectively translated and binds
to specific DNA sequences and, therefore, functionally active.
Regarding the signalling mechanism that orchestrate Jun
activation, Jun proteins can be activated by phosphorylation
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Fig. 4. Phosphorylation of c-Jun at serine-63 in the developing inner
ear. Immunohistochemical detection of c-Jun p39 phosphorylated at
serine 63 on frozen sections obtained from embryos in stage 14 and
19. At least ten embryos were fixed in 4% paraformaldehyde,
cryoprotected in sucrose and sectioned at 20 m m.
Immunohystochemistry was performed with an anti-phospho-c-Jun
mouse monoclonal antibody that reacts specifically with c-Jun p39
phosphorylated at serine 63. Arrowheads point to the spots of stained
cells present in the edges of the otic pit in stage 14, and in the dorsal
part of the otic vesicle and CVG in stage 19. Bar, 150 m m. A,
anterior; D, dorsal; CVG, cochleovestibular ganglion.
Fig. 5. Pattern of programmed cell death during early otic
development. The distribution of apoptotic cells in the otic
vesicle was determined by the TUNEL technique on frozen
sections as indicated in Materials and Methods. Chicken
embryos between stages 14 to 20 were dissected, fixed in
4% paraformaldehyde, cryoprotected in sucrose and
sectioned at 20 m m. The fragmented DNA was labelled by
the terminal deoxynucleotidyl transferase-mediated
fluorescein-dUTP nick end labelling reaction. The
incorporated fluorescein was detected by anti-fluorescein
antibody conjugated with horse-radish peroxidase
(Converter-POD). After substrate reaction, the apoptotic
nuclei were analyses under light microscope. Arrowheads
point to the apoptotic cells. The experiment shown is
representative of 3 performed with at least 6 embryos per
stage. Bar, 100 m m. A, anterior; D, dorsal; op, otic pit;
CVG, cochleovestibular ganglion; ed, endolymphatic duct.
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through two distinct pathways (Karin et al., 1997). Survival
factors induce the activation of a subgroup of MAPKs, the
extracellular signal regulated kinases (ERKs), which induce c-
jun expression and stimulation of cell proliferation. On the
other hand, serum-deprivation or NGF binding to its p75
receptor activate another set of MAPK kinases, the JNKs,
which phosphorylate c-Jun at the serine residues 63 and 73
leading to apoptosis (Kaplan and Miller, 1997; Karin et al.,
1997). JunD is phosphorylated less efficiently than c-Jun by
JNKs while JunB is not phosphorylated in response to JNKs
activation (Karin et al., 1997). The information is still
incomplete, but it points to the idea that specific
phosphorylation of Jun may specify the functional role of Jun
proteins. Our analysis of c-Jun phosphorylation at serine-63
indicates that the JNKs pathway is operating in the same areas
where c-Jun RNA transcripts are detected by in situ
hybridisation. 
To further understand the role of Jun in the otic vesicle, it
was important to test how tight was the relationship between
Jun expression, JNK-dependent Jun phosphorylation and cell
death. Our results with TUNEL analysis show that Jun
expression and JNK-dependent phosphorylation coincide with
those areas of cell death. Areas of cell death concentrate at
edges of the otic cup and later in the otic pore and the dorsal
otic vesicle around the formation of the endolymphatic duct.
Also the CVG shows areas of intense cell death. This pattern
corresponds well with previous reports based on morphological
criteria (Alvarez and Navascues, 1990). Apoptosis could be
contributing to the formation of the otic vesicle by facilitating
the migration of the upper dorsal cells and hence allowing a
closer contact between both borders and also it could be a
mechanism to allow the separation of the otic vesicle from the
ectoderm. A similar mechanism has been proposed for other
embryonic structures, including the neural tube (Weil et al.,
1997). In this connection, JNKs signalling has been implicated
in morphogenesis and JunD mutant embryos fail to close the
dorsal ectoderm in Drosophila (Noselli, 1998).
A variety of extracellular factors, intracellular signal
transducers and transcription factors interact in the otic vesicle
to regulate cell proliferation and cell death. NGF and IGF-I
have opposite actions in the otic vesicle. NGF induces
apoptosis after binding to the low affinity p75 receptor in
restricted areas of the otic vesicle and the CVG, and this effect
is completely abolished by overexpression of Raf. NGF
induces the generation of ceramide that by itself is able to
induce apoptosis in the otic vesicle (Frago et al., 1998).
Ceramide has been reported to initiate apoptosis through the
JNK cascade (Westwick et al., 1995; Verheij et al., 1996). On
the contrary, IGF-I promotes cell growth and survival in the
epithelium of the otic vesicle and in the CVG. IGF-I activates
the Raf/MAPKs pathway and increases concomitantly the
levels of Jun proteins and of the cell cycle PCNA (León et al.,
1998; Sanz et al., 1999). In this regard, it is worth noting that
apoptosis mediated by c-Jun is not associated with cell cycle
progression indicating that the role of c-Jun in apoptosis might
be distinct from its function in cell proliferation (Karin et al.,
1997). In the present work, we were able to show that NGF
induces JNKs-mediated phosphorylation of c-Jun along with
cell death. These effects are both blocked when the MAPKs
pathway is activated by either treatment with IGF-I or Raf
overexpression. This situation is analogous to those reported
for pheochromocytoma PC12 cells (Kaplan and Miller, 1997;
Leppä et al., 1998) and for mature oligodendrocytes (Yoon et
al., 1998).
In summary, we show: (i) the differential patterns of
expression of Jun proteins during inner ear organogenesis; (ii)
the presence of functional c-Jun in the otic vesicle and its
activation by phosphorylation; (iii) that these events are closely
associated with programmed cell death in the otic primordium;
and, (iv) that both c-Jun phosphorylation and apoptosis are
induced by NGF and blocked by IGF-I or Raf overexpression
in cultured otic vesicles. Taken together these results indicate
that during inner ear organogenesis the distinct expression and
activation of Jun proteins are central to achieve the specific
cellular responses required for normal development to
progress.
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Fig. 6. NGF-induction of cell death is associated with c-Jun phosphorylation in cultured otic vesicles. Otic vesicles were dissected in stage 18
and co-cultured with either uninfected CEF (A,B,C) or CEF overexpressing Raf (D) in 2% FBS for 24 hours. Explants were after cultured for
16 hours in the absence of FBS (A), or with 1 nM IGF-I plus 4 nM NGF (B) or 4 nM NGF (C). (D) Otic vesicles co-cultured with CEF
overexpressing c-Raf in the presence of 4 nM NGF and processed as above. Explanted otic vesicles were fixed in 4% paraformaldehyde,
cryoprotected in sucrose and sectioned at 20 m m. Immunohystochemistry was performed with an anti-phospho-c-Jun mouse monoclonal
antibody. The specimens shown are representative of at least seven otic vesicles per condition isolated and processed in two different days. Bar,
100 m m. CVG, cochleovestibular ganglion.
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